Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, 3-Way Crossover, Multicenter Polysomnography Study Of Pregabalin And Pramipexole In Adults With Restless Legs Syndrome.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary) ; Pramipexole
- Indications Restless legs syndrome
- Focus Registrational; Therapeutic Use
- Sponsors Pfizer
- 28 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Feb 2011 Planned end date changed from 1 Sep 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.